NPP
ONC

New Potomac Partners’s BeOne Medicines Ltd ONC Stock Holding History

New Potomac Partners’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$22.5K Buy
+100
New +$18K 0.01% 134

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

New Potomac Partners's ONC Position: Q3 2024 in Review

New Potomac Partners opened a new position in BeOne Medicines Ltd (ONC) in Q3 2024: 100 shares worth $22.5K. The stake represents 0.01% of the portfolio and ranks #134 among its holdings.

228 funds tracked by Wall St. Rank hold ONC as of Q3 2024.

  • New Potomac Partners held 100 shares of BeOne Medicines Ltd worth $22.5K as of Q3 2024.
  • BeOne Medicines Ltd was a new New Potomac Partners position in Q3 2024.
  • BeOne Medicines Ltd made up 0.01% of New Potomac Partners's portfolio in Q3 2024, its #134 holding.
  • 228 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2024.

Based on New Potomac Partners's 13F filing for Q3 2024, filed 8 Nov 2024.